If you liked this article you might like

Hillary Blasts Drug Prices, Biotech Stocks Plunge. Yes, It Could be Happening Again.
Mylan Stock Unlikely to Bottom on Epipen Price Reduction
More Squawk from Jim Cramer: Mylan (MYL) EpiPens 'Should Not Be Just for Rich People'
BTIG's Chiang Explains on CNBC Why He's Sticking With Mylan (MYL)